ECM
AGRX

ExodusPoint Capital Management’s Agile Therapeutics AGRX Stock Holding History

ExodusPoint Capital Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5
Closed -$10K – 2754
2021
Q3 		$10K Sell
5
-36
-88% -$81.5K ﹤0.01% 2023
2021
Q2 		$109K Buy
41
+32
+356% +$106K ﹤0.01% 2133
2021
Q1 		$37K Buy
+9
New +$48.6K ﹤0.01% 2044
2020
Q2 		– Sell
-19
Closed -$71K – 2118
2020
Q1 		$71K Sell
19
-26
-58% -$149K 0.01% 931
2019
Q4 		$223K Buy
+45
New +$157K 0.01% 1295

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return